LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10128-1 | GSK 690693 | LSM-1128 |  | 16048642 | |
| 10147-1 | Buparlisib | BKM120; NVP-BKM120 | LSM-1148 |  | 16654980 |
| 10164-1 | AZD8330 | ARRY-424704; ARRY-704 | LSM-1165 |  | 16666708 |
| 10141-1 | Fedratinib | SAR 302503; SAR-302503; SAR302503; TG 101348; Tg-101348; TG101348 | LSM-1142 |  | 16722836 |
| 10158-1 | AZD 5438 | KIN001-239 | LSM-1159 |  | 16747683 |
| 10112-1 | PF477736 | LSM-1112 |  | 16750408 | |
| 10069-1 | Enzastaurin | LY317615 | LSM-1069 |  | 176167 |
| 10097-1 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10047-1 | Pictilisib | Pictrelisib; GDC-0941; RG-7321 | LSM-1047 |  | 17755052 |
| 10051-1 | Lapatinib | GW-572016; Tykerb | LSM-1051 |  | 208908 |
| 10008-1 | Sorafenib | BAY-439006 | LSM-1008 |  | 216239 |
| 10159-1 | Pelitinib | EKB-569 | LSM-1160 |  | 216467 |
| 10049-1 | PLX-4720 | LSM-1049 |  | 24180719 | |
| 10031-1 | KIN001-043 | LSM-42780 |  | 24906282 | |
| 10057-1 | MK2206 | LSM-1057 |  | 24964624 | |
| 10140-1 | Momelotinib | CYT387 | LSM-1141 |  | 25062766 |
| 10134-1 | GSK1904529A | LSM-1134 |  | 25124816 | |
| 10138-1 | Ruxolitinib | LSM-1139 |  | 25126798 | |
| 10146-1 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 |  | 25167777 |
| 10115-1 | LDN-193189 | DM 3189 | LSM-1115 |  | 25195294 |
| 10100-1 | JNK-9L | KIN001-204 | LSM-36386 |  | 25222038 |
| 10016-1 | HG-5-88-01 | LSM-5245 |  | 25226117 | |
| 10015-1 | HG-5-113-01 | LSM-5982 |  | 25226483 | |
| 10064-1 | WYE-125132 | LSM-1064 |  | 25260757 | |
| 10007-1 | AZD8055 | LSM-1007 |  | 25262965 |